UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Utilizing TCR-Seq to Detect Tabelecleucel (Tab-cel), an Allogeneic Epstein–Barr Virus (EBV)-Specific T-Cell Immunotherapy, Post-Infusion

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S158

2023

Volltextzugriff (PDF)

202 - Utilizing TCR-Seq to Detect Tabelecleucel (Tab-cel), an Allogeneic Epstein–Barr Virus (EBV)-Specific T-Cell Immunotherapy, Post-Infusion

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S158-S158

2023

Volltextzugriff (PDF)

Utilizing TCR-Seq to Detect Tabelecleucel, an Allogeneic Epstein-Barr Virus (EBV)-Specific T-Cell Immunotherapy, Post-Infusion

Blood, 2022-11, Vol.140 (Supplement 1), p.4966-4967

2022

Volltextzugriff (PDF)

Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study

Cancer medicine (Malden, MA), 2022-11, Vol.11 (22), p.4134-4145

2022

Volltextzugriff (PDF)

Identifying therapeutic drug targets using bidirectional effect genes

Nature communications, 2021-04, Vol.12 (1), p.2224-2224, Article 2224

2021

Volltextzugriff (PDF)

Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter

Molecular therapy. Methods & clinical development, 2020-09, Vol.18, p.620-630

2020

Volltextzugriff (PDF)

Neurofilament light is a treatment‐responsive biomarker in CLN2 disease

Annals of clinical and translational neurology, 2019-12, Vol.6 (12), p.2437-2447

2019

Volltextzugriff (PDF)

Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas

JAMA oncology, 2017-12, Vol.3 (12), p.1654

2017

Volltextzugriff (PDF)

Comparative Survival Analysis of Invasive Breast Cancer Patients Treated by a U.S. Military Medical Center and Matched Patients From the U.S. General Population

Military medicine, 2017-11, Vol.182 (11), p.e1851-e1858

2017

Volltextzugriff (PDF)

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

Oncotarget, 2017-04, Vol.8 (17), p.28575-28587

2017

Volltextzugriff (PDF)

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition

Oncotarget, 2016-11, Vol.7 (47), p.76534-76550

2016

Volltextzugriff (PDF)

CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)

BMC cancer, 2016-09, Vol.16 (1), p.713-713, Article 713

2016

Volltextzugriff (PDF)

Abstract 3756: PARP inhibitor sensitivity in small cell lung cancer cell lines and patient-derived xenografts correlates with SLFN11 expression but not with structural homologous recombination deficiency

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3756-3756

2016

Volltextzugriff (PDF)

Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis

Clinical cancer research, 2016-03, Vol.22 (5), p.1274-1283

2016

Volltextzugriff (PDF)

Abstract A37: Talazoparib predictive biomarker analysis in human small cell lung cancer cells and PDX tumors

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.A37-A37

2015

Volltextzugriff (PDF)

Abstract 4949: HAS2 is a critical effector for AGL mediated regulation of tumor growth

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4949-4949

2015

Volltextzugriff (PDF)

Abstract P6-08-24: Age independently predicts worse disease-specific survival in patients diagnosed with invasive breast cancers at 50 years of age or older but not younger

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P6-P6-08-24

2015

Volltextzugriff (PDF)

Abstract P3-07-20: Survival comparative analysis of patients with invasive breast cancer treated by a military medical center and matched patients of the US general population

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-07-20

2015

Volltextzugriff (PDF)

SplicingTypesAnno: Annotating and quantifying alternative splicing events for RNA-Seq data

Computer methods and programs in biomedicine, 2015-04, Vol.119 (1), p.53-62

2015

Volltextzugriff (PDF)

Variable-Node-Based Dynamic Scheduling Strategy for Belief-Propagation Decoding of LDPC Codes

IEEE communications letters, 2015-02, Vol.19 (2), p.147-150

2015

Volltextzugriff (PDF)

Abstract 4604: PTP4A3 is oncogenic and modulates triple negative breast cancer growth

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4604-4604

2014

Volltextzugriff (PDF)

The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations

Nucleic acids research, 2014-09, Vol.42 (17), p.e133-e133

2014

Volltextzugriff (PDF)

Role in Tumor Growth of a Glycogen Debranching Enzyme Lost in Glycogen Storage Disease

JNCI : Journal of the National Cancer Institute, 2014-04, Vol.106 (5), p.1

2014

Volltextzugriff (PDF)

A Water-Soluble Iron Porphyrin as a Highly Efficient and Recyclable Catalyst for Peroxynitrite Decomposition

Advanced materials research, 2014, Vol.881-883, p.617-624

2014

Volltextzugriff (PDF)

Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression

Journal of thoracic oncology, 2013-12, Vol.8 (12), p.1492-1501

2013

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(18)
Humans
(16)
Oncology
(11)
Cell Line, Tumor
(8)
Animals
(7)
Mice
(7)
Urinary Bladder Neoplasms - Genetics
(7)
Female
(6)
Urinary Bladder Neoplasms - Pathology
(6)
Male
(5)
Technology
(5)
Engineering
(4)
Gene Expression
(4)
Mutation
(4)
Prognosis
(4)
Adult
(3)
Aged
(3)
Antineoplastic Agents
(3)
Biological And Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Utilizing TCR-Seq to Detect Tabelecleucel (Tab-cel), an Allogeneic Epstein–Barr Virus (EBV)-Specific T-Cell Immunotherapy, Post-Infusion

202 - Utilizing TCR-Seq to Detect Tabelecleucel (Tab-cel), an Allogeneic Epstein–Barr Virus (EBV)-Specific T-Cell Immunotherapy, Post-Infusion

Utilizing TCR-Seq to Detect Tabelecleucel, an Allogeneic Epstein-Barr Virus (EBV)-Specific T-Cell Immunotherapy, Post-Infusion

Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study

Identifying therapeutic drug targets using bidirectional effect genes

Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter

Neurofilament light is a treatment‐responsive biomarker in CLN2 disease

Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas

Comparative Survival Analysis of Invasive Breast Cancer Patients Treated by a U.S. Military Medical Center and Matched Patients From the U.S. General Population

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition

CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)

Abstract 3756: PARP inhibitor sensitivity in small cell lung cancer cell lines and patient-derived xenografts correlates with SLFN11 expression but not with structural homologous recombination deficiency

Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis

Abstract A37: Talazoparib predictive biomarker analysis in human small cell lung cancer cells and PDX tumors

Abstract 4949: HAS2 is a critical effector for AGL mediated regulation of tumor growth

Abstract P6-08-24: Age independently predicts worse disease-specific survival in patients diagnosed with invasive breast cancers at 50 years of age or older but not younger

Abstract P3-07-20: Survival comparative analysis of patients with invasive breast cancer treated by a military medical center and matched patients of the US general population

SplicingTypesAnno: Annotating and quantifying alternative splicing events for RNA-Seq data

Variable-Node-Based Dynamic Scheduling Strategy for Belief-Propagation Decoding of LDPC Codes

Abstract 4604: PTP4A3 is oncogenic and modulates triple negative breast cancer growth

The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations

Role in Tumor Growth of a Glycogen Debranching Enzyme Lost in Glycogen Storage Disease

A Water-Soluble Iron Porphyrin as a Highly Efficient and Recyclable Catalyst for Peroxynitrite Decomposition

Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression

Suchergebnisse filtern